BioSpace News Archive

Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2020 on Monday, August 10 at 4:30 p.m. ET / 1:30 p.m. PT.

Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 40th Annual Growth Conference on Wednesday, August 12, 2020.

Dosing of DNL758 (SAR443122) has commenced in a randomized, double-blind, placebo-controlled Phase 1b trial to evaluate safety and effect on the immune system in severe COVID-19 DNL758, discovered by Denali and partnered with Sanofi, is a small molecule inhibitor of RIPK1 that does not cross the blood-brain barrier, and is being developed for patients with peripheral inflammatory diseases

Vineti, the California -based company that offers a digital platform to enable broad access to advanced therapeutics, and EVERSANA™, a provider of global integrated commer

FBSciences Inc., a global leader in naturally derived plant health technologies and products, is accelerating its collaboration agreement with Yara North America by expanding its line of calcium nitrate (CN) compatible products.

#MyCleanAirStory social media campaign to amplify voices, elevate conversations and personal stories on the health impacts of climate change, air pollution

Jeffrey Koplan , MD, MPH, vice president for Global Health at Emory University , and Amelie Ramirez , DrPH, MPH, professor and chair of the Department of Population Health Sciences and director of the Institute for Health Promotion Research at UT Health San Antonio, have each been elected to a five-year term on the board of directors of t

The European Commission (EC) has approved Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord)'s Zercepac®, a biosimilar trastuzumab, for the treatment of certain patients with HER2-positive early breast cancer, HER2-positive metastatic breast cancer and previously untreated HER2-positive metastatic gastric cancer

LeMaitre Vascular, Inc. announced that it is participating in two investor conferences in August.

As healthcare organizations across the country are overwhelmed with patient intake processes, many have turned to eHealth Technologies to effectively streamline patient care